Haley Tyburski

发表

HER2-low breast cancers: Current insights and future directions.

Huina Zhang, Hani Katerji, David G. Hicks, 2022, Seminars in diagnostic pathology.

Performance of HER2 DAKO HercepTest and Ventana 4B5 Immunohistochemical Assays on Detecting HER2 Gene-Amplification in Uterine Serous Carcinomas.

Huina Zhang, Hani Katerji, B. Finkelman, 2024, Human pathology.

In ER Positive, HER2 Negative Breast Cancers, HER2 mRNA Levels Correlate Better with Clinicopathologic Features and Oncotype DX® Recurrence Score than HER2 Immunohistochemistry.

Huina Zhang, B. Turner, David G. Hicks, 2023, Laboratory investigation; a journal of technical methods and pathology.

HER2 categorical changes after neoadjuvant chemotherapy: A study of 192 matched breast cancers with the inclusion of HER2-Low category.

Huina Zhang, B. Turner, David G. Hicks, 2023, Human pathology.